Skip to content

Holding La Pharma

Active Risk: not assessed Private limited companyfounded 2025active for 1 yearGeeraard de Cremerstraat 12, 9150 Beveren-Kruibeke-ZwijndrechtKBO/BCE: BE 1021.147.605

Board

2 directors, since incorporation
Director
appointed by deed of 20-03-2025 term without a fixed end
Director
appointed by deed of 20-03-2025 term without a fixed end

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
Board
Mandates as a list
  • DERWEDUWEN Frederik
    • Director, appointed by deed of 20-03-2025, still in office
  • VAN EETVELDE Maxime Marleen Godfried
    • Director, appointed by deed of 20-03-2025, still in office

Control

Shareholder
Frederik Derweduwen
share not stated
This company
Holding La Pharma
Equity €115,136
Profit €15,136 in 2025

and 1 other shareholder

Capital

Contribution
€100,000
Shares
100
Contribution per share
€1,000
Equity per share
€1,151 in 2025
Source
deed of 20-03-2025

Articles of association

deed of 20-03-2025 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
“Algemene vergadering die bestuurder(s) benoemt, met of zonder beperking van duur”
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Helft overdrager en helft koper(s), elke overdracht onder levenden ten bezwarende en kosteloze titel vrijwillig en gedwongen met inbegrip…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May at 19:00
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Ontbinding en vereffening mag in 1 akte voor zover aan wettelijke voorwaarden voldaan, alle machten artikel 2:87 Wetboek van Vennootschappen…”

Shareholders

2 owners

Owners 2

Capital transactions

Shareholders according to the deeds
At incorporation deed of 20-03-2025 ↗
Capital over time
  1. 20-03-2025 Incorporation · €100,000 · 100 shares

Next steps